NASDAQ · Biotechnology

ABOS (ABOS) Stock

$2.27 -0.66% NASDAQ: ABOS Healthcare

Valuation

MetricValue
Price$2.27
Market Cap$163.60M
P/E Ratio-1.17
P/B Ratio2.03
P/S Ratio0.00
EPS (TTM)$-2.00
52-Week High$3.60
52-Week Low$1.10
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-172.86%
ROA-98.37%
ROCE-174.65%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.16
Current Ratio4.07

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-20.0M$-45.0M$-61.0M$-114.0M$-124.0M
Net Profit$-101.0M$-43.0M$-52.0M$-102.0M$-121.0M
EPS$-2.63$-1.06$-1.08$-1.71$-2.00
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$230.0M$197.0M$310.0M$239.0M$123.0M
Total Liabilities$5.0M$8.0M$43.0M$57.0M$52.0M
Cash$122.0M$130.0M$67.0M$36.0M$54.0M
Borrowings$0$0$28.0M$30.0M$31.0M

Latest News

All You Need to Know About Acumen Pharmaceuticals (ABOS) Rating Upgrade to Buy Zacks · Jul 15, 2026 Acumen Pharmaceuticals Shows Early Alzheimer’s Disease Insights Exec Edge · Jul 15, 2026 Are Medical Stocks Lagging Acumen Pharmaceuticals (ABOS) This Year? Zacks · Jul 15, 2026 Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026 GlobeNewswire · Jul 15, 2026 Acumen Pharmaceuticals and Unlearn Collaborate to Explore Analyses of Alzheimer's Disease Clinical Programs ACCESS Newswire · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-18.0M$-35.0M$-43.0M$-86.0M$-116.0M
Investing Cash Flow$-104.0M$39.0M$-172.0M$48.0M$134.0M
Financing Cash Flow$2.0M$0$0$0$0
Net Cash Flow$78.0M$8.0M$-63.0M$-31.0M$18.0M
Free Cash Flow$-18.0M$-35.0M$-43.0M$-86.0M$-116.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-74.15%
Quick Ratio4.55
Interest Coverage-31.00
Return 1Y69.80%
Return 3Y-59.71%
Return 5Y-85.38%

Ownership

Insiders Held6.80%
Institutions Held64.20%
Institutions Float Held68.88%
Institutional HolderSharesReport Date
RA Capital Management, L.P.20,992,6692026-03-31
Sands Capital Alternatives, LLC3,720,1052026-03-31
Alyeska Investment Group, L.p.2,454,7542026-03-31
Franklin Resources, Inc.2,305,0962026-03-31
Adar1 Capital Management, LLC 2,156,3342026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACTU $1.09 -5.22% -2.73 $26.08M 0.00%
AGENAgenus Inc. $6.06 +1.34% 3.46 $252.35M 0.00%
ALEC $1.52 +0.33% -1.58 $168.20M 0.00%
FATE $2.31 -0.43% -1.62 $269.25M 0.00%
INO $1.04 +0.97% -2.73 $55.73M 0.00%

About ABOS

ABOS is led by CEO Daniel J. O'Connell, employs 61 people, headquartered in US, publicly traded since 2021.

ABOS stock trades at $2.27 with a market capitalization of $163.60M. The stock is valued at a price-to-earnings (P/E) ratio of -1.17, price-to-book of 2.03, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.10 and $3.60, and currently trades 36.9% below its 52-week high.

On profitability, ABOS generates a return on equity (ROE) of -172.86%, return on capital employed of -174.65%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides